Document is current
Any future updates will be listed below
-
Authors
Yang, Juan https://orcid.org/0000-0001-5028-2227
Marziano, Valentina https://orcid.org/0000-0003-2842-7906
Deng, Xiaowei
Guzzetta, Giorgio https://orcid.org/0000-0002-9296-9470
Zhang, Juanjuan
Trentini, Filippo https://orcid.org/0000-0001-6915-7282
Cai, Jun https://orcid.org/0000-0001-9495-1226
Poletti, Piero https://orcid.org/0000-0001-5453-5199
Zheng, Wen
Wang, Wei
Wu, Qianhui
Zhao, Zeyao
Dong, Kaige
Zhong, Guangjie
Viboud, Cécile https://orcid.org/0000-0003-3243-4711
Merler, Stefano
Ajelli, Marco https://orcid.org/0000-0003-1753-4749
Yu, Hongjie https://orcid.org/0000-0002-6335-5648
- License Information
-
More Information
Article History
Received: 11 May 2021
Accepted: 3 June 2021
First Online: 22 June 2021
Competing interests
: H.Y. has received research funding from Sanofi Pasteur, GlaxoSmithKline, Yichang HEC Changjiang Pharmaceutical Company and Shanghai Roche Pharmaceutical Company. M.A. has received research funding from Seqirus. None of this research funding is related to COVID-19. All other authors report no competing interests.
: All these data were in the public domain. Ethical review for the re-use of these secondary data is not required.
